NCT07103564

Brief Summary

Background: Immediate implants provide ideal three-dimensional positioning compared to conventional implants. There may be a gap between the surface of the implant and the bone walls of the socket when it is inserted into a recently extracted alveolus. To compensate for this, various grafting materials are used. Recently, melatonin has gained significant attention because of its inhibitory action on bone resorption through upregulating the expression of osteoprotegerin, which acts as a decoy receptor for RANKL and inhibits its binding to osteoclast precursors thereby inhibiting osteoclast formation and activity. So, we will conduct this study to evaluate the effects of local melatonin application around immediately placed implants. Aim of the study: To evaluate the effectiveness of adding local melatonin around immediately placed implants in maxillary premolars.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2025

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

July 29, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 5, 2025

Completed
Last Updated

August 5, 2025

Status Verified

July 1, 2025

Enrollment Period

1 year

First QC Date

July 29, 2025

Last Update Submit

July 29, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in Osteoprotegerin

    OPG (Ng/ml) level will be measured preoperatively, 1 and 3 months post operatively, to evaluate the bone healing activity. The level will be evaluated by collecting 5 ml of peripheral blood in blank tubes and will be allowed for complete clotting and will be centrifuged at 1000 g for 15 min. The separated serum will be then stored at -20 0C.

    Baseline, 1 month, and 3 months

  • Change in bone volume

    CBCT scans will be obtained to measure change in bone volume

    Baseline and 6 months

  • Change in bone level

    CBCT scans will be obtained to measure change in bone level

    Baseline and 6 months

  • Change in bone density

    CBCT scans will be obtained to measure change in bone density

    Baseline and 6 months

Study Arms (2)

melatonin therapy

EXPERIMENTAL
Other: Immediately placed implant in maxillary premolars with local melatonin application

No melatonin

ACTIVE COMPARATOR
Other: Immediately placed implant in maxillary premolars without local melatonin application

Interventions

Patients will receive immediately placed implants with local melatonin powder (3mg) application.

melatonin therapy

Patients will receive immediately placed implants without local melatonin application.

No melatonin

Eligibility Criteria

Age25 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with non-restorable maxillary premolars with sufficient bone quantity to receive the dental implant without the need for bone graft.
  • Patients with no local or systemic pathology that can interfere with normal wound healing.
  • Non-smokers.
  • Patients who are properly motivated to complete follow-up visits

You may not qualify if:

  • Patients with uncontrolled medical conditions that can affect surgical outcome or bone and wound healing. (ex: uncontrolled diabetes mellitus)
  • Patients with periapical pathology that may contraindicate immediate implant placement.
  • History of receiving irradiation in the head and neck region

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Outpatient Clinic of Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Alexandria University

Alexandria, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Lecturer of Dental Public Health and biostatistical consultanat

Study Record Dates

First Submitted

July 29, 2025

First Posted

August 5, 2025

Study Start

July 1, 2024

Primary Completion

July 15, 2025

Study Completion

July 15, 2025

Last Updated

August 5, 2025

Record last verified: 2025-07

Locations